Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis
Research Article
[키워드] ACE2
ACE2 protein
acute inflammatory response
Angiotensin II
angiotensin-converting enzyme inhibitor
approach
ARB
binding
blocker
cardiovascular disease
cardiovascular diseases
Cell
cell entry
cell membrane
chronic inflammation
Chronic kidney disease
coronavirus
COVID-19
COVID-19 pandemic
diabete
diabetes
disease
disease severity
dosage
drug
Effects
enzyme
epidemiological data
epithelial cell
Evidence
exacerbated
Factors
heart failure
help
host cell
host cells
host’s immune response
hypertension
implication
increase in
induce
Infection
Inflammation
inhibitor
Invasion
lack
lethal disease
Lungs
mathematical
medication
medications
Model
modeling
Mortality
pandemic
Pandemics
pathogenesis of COVID-19
Patient
physician
predict
RAS
receptor
renin-angiotensin system
risk
SARS- CoV-2
SARS-CoV
SARS-CoV-2
severe COVID-19
subsequent
suggested
the spike protein
therapy
tissue damage
tissues
treated
Treatment
virus
while
[DOI] 10.1371/journal.pcbi.1008235 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pcbi.1008235 PMC 바로가기 [Article Type] Research Article